Cleared Traditional

K023913 - NEUROTECH BAXOLVE TYPE 294

K023913 is an FDA 510(k) clearance for NEUROTECH BAXOLVE TYPE 294, manufactured by Bio-Medical Research, Ltd.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 273-day FDA review.

K023913 · Bio-Medical Research, Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2003
Decision
273d
Days
Class 2
Risk

K023913 is an FDA 510(k) clearance for the NEUROTECH BAXOLVE TYPE 294. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Bio-Medical Research, Ltd. (Galway, IE). The FDA issued a Cleared decision on August 25, 2003 after a review of 273 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K023913

510(k) Number K023913 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 2002
Decision Date August 25, 2003
Days to Decision 273 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 149d · This submission: 273d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 597
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K023913.
S21 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR
K033253 · Micro Current Technology, Inc. · Oct 2003
MEDS-4-INF+
K032055 · Medical Equipment Device Specialists · Oct 2003
E275
K032653 · Micro Current Technology, Inc. · Sep 2003
TENS PRO 900
K023726 · Acumed Medical Supplies , Ltd. · Jun 2003
BODY CLOCK TENS N' TONE
K022849 · Body Clock Health Care, Ltd. · May 2003
HIVOX DREAMATE DM-800
K021952 · Hivox Biotek, Inc. · May 2003
K023913 · NEUROTECH BAXOLVE TYPE 294
Download PDF FDA Summary Bio-Medical Research,…